The Pharmaceutical Journal
Vol 278 No 7451 p547
12 May 2007

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Products

SPC changes
• Buspar
Discontinued products
• Stelazine Spansules
Products miscellany
• Iodoflex and Iodosorb
• Nepro Tetrapak

SPC changes

Buspar
The summary of product characteristics for Buspar (buspirone; Bristol-Myers Squibb) now states that Buspar contains lactose and that patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take Buspar. See SPC.

Back to Top

Discontinued products

Stelazine Spansules
Stelazine Spansules (trifluoperazine) 2mg, 10mg and 15mg have been discontinued by Goldshield following a long-term supply problem. Stelazine tablets 1mg and 5mg remain available. Medical information on 020 8588 9131.

Back to Top

Products miscellany

Iodoflex and Iodosorb
Iodoflex and Iodosorb (cadexomer with iodine; Smith & Nephew) wound dressings have been reclassified from pharmaceutical products to medical device wound dressings. From 1 May these products will appear in the dressings section of the Drug Tariff.

Nepro Tetrapak
Nepro Tetrapak is now available from Abbott Nutrition and is approved by the Advisory Committee on Borderline Substances (ACBS). Net price: 200ml pack, £2.28.

Back to Top